Spotlight Asset Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.46M | Hold |
82,100
| – | – | 1.02% | 23 |
|
|
2024
Q1 | $1.25M | Buy |
82,100
+3,100
| +4% | +$47.2K | 0.89% | 23 |
|
|
2023
Q4 | $660K | Hold |
79,000
| – | – | 0.6% | 29 |
|
|
2023
Q3 | $660K | Buy |
79,000
+4,000
| +5% | +$33.4K | 0.6% | 29 |
|
|
2023
Q2 | $1.86M | Hold |
75,000
| – | – | 1.67% | 15 |
|
|
2023
Q1 | $391K | Buy |
+75,000
| New | +$391K | 0.39% | 46 |
|
|
2022
Q3 | $391K | Buy |
+75,000
| New | +$391K | 0.39% | 46 |
|
|
2021
Q3 | $2.5M | Hold |
75,000
| – | – | 1.24% | 19 |
|
|
2021
Q2 | $2.91M | Hold |
75,000
| – | – | 1.12% | 19 |
|
|
2021
Q1 | $3.62M | Buy |
75,000
+20,000
| +36% | +$964K | 1.36% | 16 |
|
|
2020
Q4 | $2.86M | Hold |
55,000
| – | – | 1.06% | 17 |
|
|
2020
Q3 | $1.47M | Hold |
55,000
| – | – | 0.58% | 25 |
|
|
2020
Q2 | $1.07M | Hold |
55,000
| – | – | 0.45% | 38 |
|
|
2020
Q1 | $541K | Hold |
55,000
| – | – | 0.29% | 54 |
|
|
2019
Q4 | $576K | Buy |
+55,000
| New | +$576K | 0.27% | 56 |
|